再次手术后乳头甲状腺癌复发的预测因素:回顾性分析
Sang Chun Park1, Sang Ho Jo1, Hee Won Ryu1
1Department of Surgery, Chonnam National University Hwasun Hospital, Jeollanam-do, South Korea.
Gland surgery
|October 27, 2025
概括
乳头甲状腺癌复发的预测是先进的T4a初始阶段和术后升高的甲状腺蛋白 (Tg) 水平. 密切监测对于这些高风险患者至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 手术瘤学手术瘤学
背景情况:
- 乳头甲状腺癌 (PTC) 的复发会影响患者的治疗结果,需要有效的治疗策略.
- 区分持久性疾病与真正的复发对于优化治疗至关重要.
- 在初始治疗后,PTC复发的风险因素存在有限的研究.
研究的目的:
- 为了确定状甲状腺癌患者复发的风险因素.
- 分析甲状腺全切除术和部解剖术后复发的预测因素.
主要方法:
- 对158名经过重复手术的PTC患者的回顾性审查.
- 使用Cox比例危险模型和Kaplan-Meier生存分析进行分析.
- 再手术后的中位数随访时间为101.3个月.
主要成果:
- 复发发生在17.1%的患者中.
- 最初的T4阶段,淋巴结比率>0.7,和未刺激的Tg≥1 ng/mL与更糟糕的无复发生存率有关.
- 多变量分析确定T4a阶段 (HR 2.782) 和非刺激的最大Tg ≥1 ng/mL后再手术 (HR 2.427) 作为重复复发的显著预测因素.
结论:
- 在T4a阶段和术后Tg水平升高是PTC复发的强有力的预测因素.
- 建议在重新手术后对T4a阶段或Tg水平升高的患者进行成像的短期随访.
更多相关视频
04:01Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
Published on: September 15, 2023
1.4K
05:25Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy
Published on: October 24, 2025
367
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
